• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
  • Donate
  • Contact
  • Show SearchSearch

Echinacea

March 1, 2025

Selected References:

  • Barcz E, et al. 2007. Influence of Echinacea purpurea intake during pregnancy on fetal growth and tissue angiogenic activity. Folia Histochemica et Cytobiologica 45:Supp. 1; 35-39.
  • Chow G, et al. 2006. Dietary echinacea purpurea during murine pregnancy: Effect on maternal hemopoiesis and fetal growth. Biol Neonate; 89: 133-138.
  • Gallo M, et al. 2000. Pregnancy outcome following gestational exposure to echinacea. Arch Intern Med. 160:3141-3143.
  • Heitmann K, et al. 2016. Pregnancy outcome after prenatal exposure to echinacea: The Norwegian Mother and Child Cohort Study. Eur J Clin Pharmacol. 72(5): 623-630.
  • Huntley AL, et al. 2005. The safety of herbal medicinal products derived from Echinacea species. Drug Saf 28(5):387-400.
  • Lewicka A, et al. 2019. Supplementation of plants with immunomodulatory properties during pregnancy and lactation—maternal and offspring health effects. Nutrients 11(8):1958.
  • Linde K, et al. 2009. Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews 2(2):CD000530
  • Matthias A, et al. 2008. Bioavailability of Echinacea alkamides in human breast milk. Planta Med; 74-SL59.
  • Natural Standard (Ed). Herbs & Supplements – Echinacea (E. angustifolia DC, E. pallida, E. purpurea). Nature Medicine Quality Standard. [Retrieved on November 2014]. naturalstandard.com
  • Ondrizek RR, et al. 1999. Inhibition of human sperm motility by specific herbs used in alternative medicine. J Assist Reprod Genet. 16(2):87-91.
  • Perri D, et al. 2006. Safety and efficacy of echinacea (Echinacea angustifolia, E. purpurea and E. pallida) during pregnancy and lactation. Can J Clin Pharmacol 13(3):e261-7.
  • Peprah P, et al 2019. ‘We are nothing without herbs’: a story of herbal remedies use during pregnancy in rural Ghana. BMC 19(1):65.
  • Sarecka-Hujar B, Szulc-Musioł B. 2022 Herbal Medicines—Are They Effective and Safe during Pregnancy? Pharmaceutics; 14(1):171.

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Constipation
  • Coronavirus (COVID-19)
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.